By the end of 2022, the global automated cell biology systems market is anticipated to be worth USD 14.1 Billion, and it will grow at a CAGR of 9.0% to reach an expected valuation of around USD 33.5 Billion by the year 2032. Infinite cell line cultures dominate the worldwide market in 2021, with a share of around 76.2%, according to a recent analysis by Future Market Insights.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 14.1 Billion |
| Market Value 2032 | USD 33.5 Billion |
| CAGR 2022 to 2032 | 9.0% |
| Market Share of Top 5 Countries | 62.3% |
| Key Market Players | Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Hitachi. Ltd, Nanoentek, ChemoMetec, Danaher Corporation, Agilent Technologies, Perkin Elmer (Nexcelom Bioscience LLC.), F. Hoffmann-La Roche AG, SHIMADZU CORPORATION, Bio-Rad Laboratories, Miltenyi Biotec, Sinfonia Technology, SHIBUYA CORPORATION, Advanced Instruments, Cell Culture Company, LLC, BD, and Hamilton Company |
Compared to the widespread methods utilized in the second half of the twentieth century, modern cell cultivation techniques are not significantly different. Despite the fact that these techniques made it possible to comprehend a variety of biological processes and that they served as determining factors for applications like drug testing and tissue regeneration, they had a number of inherent drawbacks. In actuality, conventional cell culture systems necessitate numerous and intricate manual handling techniques, which restricts the consistency of the cultivation in terms of cell yield and activity.
Additionally, long-term cell maintenance is costly, time-consuming, and demands a lot of reagents, test samples, and work. By reducing the number of operator interventions, the shift to user-friendly automated devices would favor standardizing the cultivation process, cutting production costs, and shortening the time required for cell culture preparation, thus promoting market growth for automated cell biology systems.
The market value for automated cell biology systems was approximately 65.8% of the overall ~USD 19.9 Billion global bioprocess technology market in 2021.
The sale of automated cell biology systems expanded at a CAGR of 6.6% from 2015 to 2021.
Technologies like microfluidics and lab-on-a-chip represent a strategic approach to support the shift to user-friendly automated equipment. By using microculture systems in place of conventional Petri plates and flasks for cellular tests, researchers have been able to minimize the number of reagents used while still achieving high-throughput cell generation and culture in a controlled setting.
The development of tissue engineering aims to increase the possibility of replacing tissue development for regenerating or restoring organ and tissue function. Tissue engineering technology has advanced significantly in recent years, and it is now widely used in domains other than medicine, such as organs-on-a-chip, bioelectronic devices, cultured meats, and so on.
Cell culture is the primary method used for tissue engineering manufacturing. Therefore, it is crucial for tissue engineering research to maintain high standards for cell culture settings.
Modern uses of analytical system automation include clinical, pharmacological, and biomedical environments. The automatic system has played a significant role in both qualitative and quantitative analysis. Optically driven, electrochemical, and mass spectroscopic approaches have all been used as analytical techniques. Robotic automation lowers the cost of analysis while providing high precision and high system throughput.
Numerous lab-on-chip advancements have been made for cell culture and certain other biomedical applications. A cell culture device indicates the viability of the cells, nutrient consumption, nutrient output in the fermentation process, and pharmacological effect.
Because of the aforementioned factors, it is anticipated that from 2022 to 2032, the global automated cell biology systems market will expand at a CAGR of 9.0%.
As automated cell culture, on-chip is widely acknowledged as a benchmark parameter in existing microfluidic systems for cell biology, and a plethora of studies have been documented in the literature. At the research laboratory level, the minimization and downsizing of additional peripheral equipment are considered a fundamental necessity for the utilization of automated devices in cell culture, coupled with the need for systems that are ready-to-use in a plug-and-play mode.
Currently, the use of micro-devices for fluidic control is limited to the use of relatively complicated, specialized, and bulky external equipment and macro-to-micro interface systems, necessitating the ongoing assistance of human operators to manage fluid flow in an unstandardized and manual manner.
The systematic application of a suitably integrated control system for accurate fluid handling in a remote control framework will significantly improve the usability and readout dependability of micro-bioreactors. This is crucial in automating cell culture techniques, reducing human involvement, and significantly lowering the number of connection tubes, intake and output ports, and bulky external equipment.
The adoption of such control systems is gaining traction, owing to the above-mentioned factors, and this is set to pose lucrative opportunities for growth within the global automated cell biology systems market during the forecasted years.
Cell-based therapies have the ability to provide a successful treatment for medical disorders that are presently incurable. Their widespread commercialization has been put at risk by constraints such as scaling up and automating labor-intensive research discoveries, high production costs, and batch variance in large-scale automated manufacturing.
Additionally, even though many cell culture labs employ automated tools to do away with manual duties like handling plates, highly-trained lab staff are still required to spend hours every day maintaining these devices. As a result, the majority of benchtop automation has limitations in terms of scaling in cell culture facilities.
Furthermore, the utilization of mammalian cell culture is quickly expanding. Even though the fundamental processes for sustaining cells are quite repeatable, the majority of cell culture operations are still done by hand.
Personnel is required to perform repetitive tasks for hours on end each day, and frequently they must come in after regular working hours to cater to the cells or modify their biology to accommodate the workload. Both the workflow's throughput and its ability to be tracked are limited by this dependence on manual steps.
With the above-mentioned factors, the market for automated cell biology systems experiences a restraint in growth.
With a market share of 89.8% in all of North America in 2021, the USA presently dominates the region and is expected to sustain this growth throughout the forecast period.
The increasing expenditure on Research and Development in the area can be attributed to the market's expansion. Additionally, the expansion of pharmaceutical firms and manufacturers in the area together with rising public awareness of stem cell therapy is anticipated to significantly contribute to the market's expansion. Additionally, it is predicted that the rising number of bone marrow and cord blood transplants across the region will favorably influence market growth.
China represents roughly 64.9% of the East Asia market in 2021, with growth at a lucrative CAGR of 13.7% throughout the forecast period. China has a significant demand for automation, according to the International Federation of Robotics (IFR). According to sales volume, China was one of the top five markets for industrial robots in 2015.
The China Robot Industry Alliance estimates that Chinese robot suppliers sold about 20,400 units in 2015, increasing their share of the global market from 25% to 29% from 2013 until 2015. With the growing wave in automation, as well as its adoption, China is posed to be a highly lucrative market for automated cell biology systems over the forecast period.
During the forecast years, Germany is projected to grow at a CAGR of nearly 7.2% in the global automated cell biology systems market. The European Medicinal Agency (EMA) granted the CliniMACS Prodigy platform approval for the commercial manufacturing process in 2018 for the customization of protocols, which is accomplished through modularity and flexible programming, allowing its use for a number of different cell types, including the development of CAR-T cells, macrophages, virus-specific T-cells, and dendritic cells. With the manufacturing of such capable platforms, Germany is set to aid with the growth of the overall market during the projected period.
Automated cell counters (single function) are the leading segment as a product, hold approximately 34.6% market share in 2021, and are expected to present high growth at a CAGR of 8.1% throughout the forecast period. The benefit of using an automated cell counter is that it largely eliminates human bias from the cell counting process. They can count more cells and are frequently faster than manually counting, which improves statistical accuracy. Automated cell counters are also employed in research and clinical labs. They can be used on urine and blood samples to count the different cell types present or to evaluate the viability of a cultivated cell line for investigation.
Infinite cell line cultures hold a global market share of around 76.2%, in 2021. Infinite cell line cultures are more robust and convenient to work with than primary cells since they can reproduce indefinitely. Infinite cell line cultures are also convenient for researchers because they are less expensive, easier to use, and able to survive more stages than primary cells. Because cell lines have a limitless supply of material and are simple to alter and grow, they are preferred for multiple screenings.
Drug development holds a share of around 35.4% in 2021, and this segment is expected to display gradual growth over the forecast period. New scientific developments in basic research, drug development, drug discovery, and customized medicine applications are being driven by 3D cell cultures. To understand the full potential of the technology, researchers can operate more efficiently with complex reagents and precious cells with the aid of high throughput, automated liquid handling solutions.
Biopharmaceutical companies hold the highest market share value of 27.4% during the year 2021. Growing drug development activities propelled by the rising demand for personalized medicine will propel this segment in terms of growth during the projected years. With the standardization of laboratory protocols, as well as the utilization of automated systems for process control technologies during the production process, this segment gains a higher share among the rest of the end users within the global market.
Key players in the market present novel solutions for the lab automation processes for cell biology systems. Moreover, with increasing approvals from the regulatory authorities for software-based total lab automation systems, the key players are presented with an opportunistic outlook for growth during the forecast period.
Similarly, recent developments related to companies manufacturing automated cell biology systems have been tracked by the team at Future Market Insights, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2015 to 2021 |
| Market Analysis | USD Billion for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, North Africa, and South Africa |
| Key Market Segments Covered | Product, Cell Culture, Application, End User, and Region |
| Key Companies Profiled | Thermo Fisher Scientific; Corning Incorporated; Merck KGaA; Lonza; Sartorius AG; Hitachi. Ltd; Nanoentek; ChemoMetec; Danaher corporation; Agilent Technologies; Perkin Elmer (Nexcelom Bioscience LLC.); F. Hoffmann-La Roche AG; SHIMADZU CORPORATION; Bio-Rad Laboratories; Miltenyi Biotec; Sinfonia Technology; SHIBUYA CORPORATION; Advanced Instruments; Cell Culture Company, LLC; BD; Hamilton Company |
| Pricing | Available upon Request |
Table 01: Global Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product
Table 02: Global Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product
Table 03: Global Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture
Table 04: Global Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application
Table 05: Global Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User
Table 06: North America Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country
Table 07: North America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product
Table 08: North America Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product
Table 09: North America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture
Table 10: North America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application
Table 11: North America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User
Table 12: Latin America Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country
Table 13: Latin America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product
Table 14: Latin America Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product
Table 15: Latin America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture
Table 16: Latin America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application
Table 17: Latin America Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User
Table 18: Europe Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country
Table 19: Europe Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product
Table 20: Europe Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product
Table 21: Europe Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture
Table 22: Europe Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application
Table 23: Europe Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User
Table 24: South Asia Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country
Table 25: South Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product
Table 26: South Asia Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product
Table 27: South Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture
Table 28: South Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application
Table 29: South Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User
Table 30: East Asia Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country
Table 31: East Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product
Table 32: East Asia Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product
Table 33: East Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture
Table 34: East Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application
Table 35: East Asia Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User
Table 36: Oceania Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country
Table 37: Oceania Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product
Table 38: Oceania Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product
Table 39: Oceania Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture
Table 40: Oceania Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application
Table 41: Oceania Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User
Table 42: MEA Market Value (US$ Million) Analysis 2015 to 2021 and Forecast 2022 to 2032, by Country
Table 43: MEA Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Product
Table 44: MEA Market Volume (Units) Analysis and Forecast 2015 to 2032, by Product
Table 45: MEA Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Cell Culture
Table 46: MEA Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by Application
Table 47: MEA Market Value (US$ Million) Analysis and Forecast 2015 to 2032, by End User
Figure 01: Global Market Volume (Units), 2015 – 2021
Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis,
Figure 03: Automated Cell Biology Systems, Pricing Analysis per unit (US$), in 2022
Figure 04: Automated Cell Biology Systems, Pricing Forecast per unit (US$), in 2032
Figure 05: Global Market Value (US$ Million) Analysis, 2015 to 2021
Figure 06: Global Market Forecast & Y-o-Y Growth, 2022 to 2032
Figure 07: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2021–2032
Figure 08: Global Market Value Share (%) Analysis 2022 and 2032, by Product
Figure 09: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Product
Figure 10: Global Market Attractiveness Analysis 2022 to 2032, by Product
Figure 11: Global Market Value Share (%) Analysis 2022 and 2032, by Cell Culture
Figure 12: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Cell Culture
Figure 13: Global Market Attractiveness Analysis 2022 to 2032, by Cell Culture
Figure 14: Global Market Value Share (%) Analysis 2022 and 2032, by Application
Figure 15: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Application
Figure 16: Global Market Attractiveness Analysis 2022 to 2032, by Application
Figure 17: Global Market Value Share (%) Analysis 2022 and 2032, by End User
Figure 18: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by End User
Figure 19: Global Market Attractiveness Analysis 2022 to 2032, by End User
Figure 20: Global Market Value Share (%) Analysis 2022 and 2032, by Region
Figure 21: Global Market Y-o-Y Growth (%) Analysis 2021 to 2032, by Region
Figure 22: Global Market Attractiveness Analysis 2022 to 2032, by Region
Figure 23: North America Market Value (US$ Million) Analysis, 2015 to 2021
Figure 24: North America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 25: North America Market Value Share, by Product (2022 E)
Figure 26: North America Market Value Share, by Cell Culture (2022 E)
Figure 27: North America Market Value Share, by Application (2022 E)
Figure 28: North America Market Value Share, by End User (2022 E)
Figure 29: North America Market Value Share, by Country (2022 E)
Figure 30: North America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 31: North America Market Attractiveness Analysis by Cell Culture, 2022 to 2032
Figure 32: North America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 33: North America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 34: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 35: U.S. Market Value Proportion Analysis, 2021
Figure 36: Global Vs. U.S. Growth Comparison
Figure 37: U.S. Market Share Analysis (%) by Product, 2021 & 2032
Figure 38: U.S. Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 39: U.S. Market Share Analysis (%) by Application, 2021 & 2032
Figure 40: U.S. Market Share Analysis (%) by End User, 2021 & 2032
Figure 41: Canada Market Value Proportion Analysis, 2021
Figure 42: Global Vs. Canada. Growth Comparison
Figure 43: Canada Market Share Analysis (%) by Product, 2021 & 2032
Figure 44: Canada Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 45: Canada Market Share Analysis (%) by Application, 2021 & 2032
Figure 46: Canada Market Share Analysis (%) by End User, 2021 & 2032
Figure 47: Latin America Market Value (US$ Million) Analysis, 2015 to 2021
Figure 48: Latin America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 49: Latin America Market Value Share, by Product (2022 E)
Figure 50: Latin America Market Value Share, by Cell Culture (2022 E)
Figure 51: Latin America Market Value Share, by Application (2022 E)
Figure 52: Latin America Market Value Share, by End User (2022 E)
Figure 53: Latin America Market Value Share, by Country (2022 E)
Figure 54: Latin America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 55: Latin America Market Attractiveness Analysis by Cell Culture, 2022 to 2032
Figure 56: Latin America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 57: Latin America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 58: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 59: Mexico Market Value Proportion Analysis, 2021
Figure 60: Global Vs Mexico Growth Comparison
Figure 61: Mexico Market Share Analysis (%) by Product, 2021 & 2032
Figure 62: Mexico Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 63: Mexico Market Share Analysis (%) by Application, 2021 & 2032
Figure 64: Mexico Market Share Analysis (%) by End User, 2021 & 2032
Figure 65: Brazil Market Value Proportion Analysis, 2021
Figure 66: Global Vs. Brazil. Growth Comparison
Figure 67: Brazil Market Share Analysis (%) by Product, 2021 & 2032
Figure 68: Brazil Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 69: Brazil Market Share Analysis (%) by Application, 2021 & 2032
Figure 70: Brazil Market Share Analysis (%) by End User, 2021 & 2032
Figure 71: Argentina Market Value Proportion Analysis, 2021
Figure 72: Global Vs Argentina Growth Comparison
Figure 73: Argentina Market Share Analysis (%) by Product, 2021 & 2032
Figure 74: Argentina Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 75: Argentina Market Share Analysis (%) by Application, 2021 & 2032
Figure 76: Argentina Market Share Analysis (%) by End User, 2021 & 2032
Figure 77: Europe Market Value (US$ Million) Analysis, 2015 to 2021
Figure 78: Europe Market Value (US$ Million) Forecast, 2022 to 2032
Figure 79: Europe Market Value Share, by Product (2022 E)
Figure 80: Europe Market Value Share, by Cell Culture (2022 E)
Figure 81: Europe Market Value Share, by Application (2022 E)
Figure 82: Europe Market Value Share, by End User (2022 E)
Figure 83: Europe Market Value Share, by Country (2022 E)
Figure 84: Europe Market Attractiveness Analysis by Product, 2022 to 2032
Figure 85: Europe Market Attractiveness Analysis by Cell Culture, 2022 to 2032
Figure 86: Europe Market Attractiveness Analysis by Application, 2022 to 2032
Figure 87: Europe Market Attractiveness Analysis by End User, 2022 to 2032
Figure 88: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 89: UK Market Value Proportion Analysis, 2021
Figure 90: Global Vs. UK Growth Comparison
Figure 91: UK Market Share Analysis (%) by Product, 2021 & 2032
Figure 92: UK Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 93: UK Market Share Analysis (%) by Application, 2021 & 2032
Figure 94: UK Market Share Analysis (%) by End User, 2021 & 2032
Figure 95: Germany Market Value Proportion Analysis, 2021
Figure 96: Global Vs. Germany Growth Comparison
Figure 97: Germany Market Share Analysis (%) by Product, 2021 & 2032
Figure 98: Germany Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 99: Germany Market Share Analysis (%) by Application, 2021 & 2032
Figure 100: Germany Market Share Analysis (%) by End User, 2021 & 2032
Figure 101: Italy Market Value Proportion Analysis, 2021
Figure 102: Global Vs. Italy Growth Comparison
Figure 103: Italy Market Share Analysis (%) by Product, 2021 & 2032
Figure 104: Italy Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 105: Italy Market Share Analysis (%) by Application, 2021 & 2032
Figure 106: Italy Market Share Analysis (%) by End User, 2021 & 2032
Figure 107: France Market Value Proportion Analysis, 2021
Figure 108: Global Vs France Growth Comparison
Figure 109: France Market Share Analysis (%) by Product, 2021 & 2032
Figure 110: France Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 111: France Market Share Analysis (%) by Application, 2021 & 2032
Figure 112: France Market Share Analysis (%) by End User, 2021 & 2032
Figure 113: Spain Market Value Proportion Analysis, 2021
Figure 114: Global Vs Spain Growth Comparison
Figure 115: Spain Market Share Analysis (%) by Product, 2021 & 2032
Figure 116: Spain Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 117: Spain Market Share Analysis (%) by Application, 2021 & 2032
Figure 118: Spain Market Share Analysis (%) by End User, 2021 & 2032
Figure 119: Russia Market Value Proportion Analysis, 2021
Figure 120: Global Vs Russia Growth Comparison
Figure 121: Russia Market Share Analysis (%) by Product, 2021 & 2032
Figure 122: Russia Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 123: Russia Market Share Analysis (%) by Application, 2021 & 2032
Figure 124: Russia Market Share Analysis (%) by End User, 2021 & 2032
Figure 125: BENELUX Market Value Proportion Analysis, 2021
Figure 126: Global Vs BENELUX Growth Comparison
Figure 127: BENELUX Market Share Analysis (%) by Product, 2021 & 2032
Figure 128: BENELUX Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 129: BENELUX Market Share Analysis (%) by Application, 2021 & 2032
Figure 130: BENELUX Market Share Analysis (%) by End User, 2021 & 2032
Figure 131: East Asia Market Value (US$ Million) Analysis, 2015 to 2021
Figure 132: East Asia Market Value (US$ Million) Forecast, 2022 to 2032
Figure 133: East Asia Market Value Share, by Product (2022 E)
Figure 134: East Asia Market Value Share, by Cell Culture (2022 E)
Figure 135: East Asia Market Value Share, by Application (2022 E)
Figure 136: East Asia Market Value Share, by End User (2022 E)
Figure 137: East Asia Market Value Share, by Country (2022 E)
Figure 138: East Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 139: East Asia Market Attractiveness Analysis by Cell Culture, 2022 to 2032
Figure 140: East Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 141: East Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 142: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 143: China Market Value Proportion Analysis, 2021
Figure 144: Global Vs. China Growth Comparison
Figure 145: China Market Share Analysis (%) by Product, 2021 & 2032
Figure 146: China Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 147: China Market Share Analysis (%) by Application, 2021 & 2032
Figure 148: China Market Share Analysis (%) by End User, 2021 & 2032
Figure 149: Japan Market Value Proportion Analysis, 2021
Figure 150: Global Vs. Japan Growth Comparison
Figure 151: Japan Market Share Analysis (%) by Product, 2021 & 2032
Figure 152: Japan Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 153: Japan Market Share Analysis (%) by Application, 2021 & 2032
Figure 154: Japan Market Share Analysis (%) by End User, 2021 & 2032
Figure 155: South Korea Market Value Proportion Analysis, 2021
Figure 156: Global Vs South Korea Growth Comparison
Figure 157: South Korea Market Share Analysis (%) by Product, 2021 & 2032
Figure 158: South Korea Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 159: South Korea Market Share Analysis (%) by Application, 2021 & 2032
Figure 160: South Korea Market Share Analysis (%) by End User, 2021 & 2032
Figure 161: South Asia Market Value (US$ Million) Analysis, 2015 to 2021
Figure 162: South Asia Market Value (US$ Million) Forecast, 2022 to 2032
Figure 163: South Asia Market Value Share, by Product (2022 E)
Figure 164: South Asia Market Value Share, by Cell Culture (2022 E)
Figure 165: South Asia Market Value Share, by Application (2022 E)
Figure 166: South Asia Market Value Share, by End User (2022 E)
Figure 167: South Asia Market Value Share, by Country (2022 E)
Figure 168: South Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 169: South Asia Market Attractiveness Analysis by Cell Culture, 2022 to 2032
Figure 170: South Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 171: South Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 172: South Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 173: India Market Value Proportion Analysis, 2021
Figure 174: Global Vs. India Growth Comparison
Figure 175: India Market Share Analysis (%) by Product, 2021 & 2032
Figure 176: India Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 177: India Market Share Analysis (%) by Application, 2021 & 2032
Figure 178: India Market Share Analysis (%) by End User, 2021 & 2032
Figure 179: Indonesia Market Value Proportion Analysis, 2021
Figure 180: Global Vs. Indonesia Growth Comparison
Figure 181: Indonesia Market Share Analysis (%) by Product, 2021 & 2032
Figure 182: Indonesia Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 183: Indonesia Market Share Analysis (%) by Application, 2021 & 2032
Figure 184: Indonesia Market Share Analysis (%) by End User, 2021 & 2032
Figure 185: Malaysia Market Value Proportion Analysis, 2021
Figure 186: Global Vs. Malaysia Growth Comparison
Figure 187: Malaysia Market Share Analysis (%) by Product, 2021 & 2032
Figure 188: Malaysia Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 189: Malaysia Market Share Analysis (%) by Application, 2021 & 2032
Figure 190: Malaysia Market Share Analysis (%) by End User, 2021 & 2032
Figure 191: Thailand Market Value Proportion Analysis, 2021
Figure 192: Global Vs. Thailand Growth Comparison
Figure 193: Thailand Market Share Analysis (%) by Product, 2021 & 2032
Figure 194: Thailand Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 195: Thailand Market Share Analysis (%) by Application, 2021 & 2032
Figure 196: Thailand Market Share Analysis (%) by End User, 2021 & 2032
Figure 197: Oceania Market Value (US$ Million) Analysis, 2015 to 2021
Figure 198: Oceania Market Value (US$ Million) Forecast, 2022 to 2032
Figure 199: Oceania Market Value Share, by Product (2022 E)
Figure 200: Oceania Market Value Share, by Cell Culture (2022 E)
Figure 201: Oceania Market Value Share, by Application (2022 E)
Figure 202: Oceania Market Value Share, by End User (2022 E)
Figure 203: Oceania Market Value Share, by Country (2022 E)
Figure 204: Oceania Market Attractiveness Analysis by Product, 2022 to 2032
Figure 205: Oceania Market Attractiveness Analysis by Cell Culture, 2022 to 2032
Figure 206: Oceania Market Attractiveness Analysis by Application, 2022 to 2032
Figure 207: Oceania Market Attractiveness Analysis by End User, 2022 to 2032
Figure 208: Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 209: Australia Market Value Proportion Analysis, 2021
Figure 210: Global Vs. Australia Growth Comparison
Figure 211: Australia Market Share Analysis (%) by Product, 2021 & 2032
Figure 212: Australia Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 213: Australia Market Share Analysis (%) by Application, 2021 & 2032
Figure 214: Australia Market Share Analysis (%) by End User, 2021 & 2032
Figure 215: New Zealand Market Value Proportion Analysis, 2021
Figure 216: Global Vs New Zealand Growth Comparison
Figure 217: New Zealand Market Share Analysis (%) by Product, 2021 & 2032
Figure 218: New Zealand Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 219: New Zealand Market Share Analysis (%) by Application, 2021 & 2032
Figure 220: New Zealand Market Share Analysis (%) by End User, 2021 & 2032
Figure 221: Middle East & Africa Market Value (US$ Million) Analysis, 2015 to 2021
Figure 222: Middle East & Africa Market Value (US$ Million) Forecast, 2022 to 2032
Figure 223: Middle East & Africa Market Value Share, by Product (2022 E)
Figure 224: Middle East & Africa Market Value Share, by Cell Culture (2022 E)
Figure 225: Middle East & Africa Market Value Share, by Application (2022 E)
Figure 226: Middle East & Africa Market Value Share, by End User (2022 E)
Figure 227: Middle East & Africa Market Value Share, by Country (2022 E)
Figure 228: Middle East & Africa Market Attractiveness Analysis by Product, 2022 to 2032
Figure 229: Middle East & Africa Market Attractiveness Analysis by Cell Culture, 2022 to 2032
Figure 230: Middle East & Africa Market Attractiveness Analysis by Application, 2022 to 2032
Figure 231: Middle East & Africa Market Attractiveness Analysis by End User, 2022 to 2032
Figure 232: Middle East & Africa Market Attractiveness Analysis by Country, 2022 to 2032
Figure 233: GCC Countries Market Value Proportion Analysis, 2021
Figure 234: Global Vs GCC Countries Growth Comparison
Figure 235: GCC Countries Market Share Analysis (%) by Product, 2021 & 2032
Figure 236: GCC Countries Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 237: GCC Countries Market Share Analysis (%) by Application, 2021 & 2032
Figure 238: GCC Countries Market Share Analysis (%) by End User, 2021 & 2032
Figure 239: Turkey Market Value Proportion Analysis, 2021
Figure 240: Global Vs. Turkey Growth Comparison
Figure 241: Turkey Market Share Analysis (%) by Product, 2021 & 2032
Figure 242: Turkey Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 243: Turkey Market Share Analysis (%) by Application, 2021 & 2032
Figure 244: Turkey Market Share Analysis (%) by End User, 2021 & 2032
Figure 245: South Africa Market Value Proportion Analysis, 2021
Figure 246: Global Vs. South Africa Growth Comparison
Figure 247: South Africa Market Share Analysis (%) by Product, 2021 & 2032
Figure 248: South Africa Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 249: South Africa Market Share Analysis (%) by Application, 2021 & 2032
Figure 250: South Africa Market Share Analysis (%) by End User, 2021 & 2032
Figure 251: North Africa Market Value Proportion Analysis, 2021
Figure 252: Global Vs North Africa Growth Comparison
Figure 253: North Africa Market Share Analysis (%) by Product, 2021 & 2032
Figure 254: North Africa Market Share Analysis (%) by Cell Culture, 2021 & 2032
Figure 255: North Africa Market Share Analysis (%) by Application, 2021 & 2032
Figure 256: North Africa Market Share Analysis (%) by End User, 2021 & 2032
The global automated cell biology systems market stands at USD 14.1 Billion in 2022 and is set to expand 2.4X over the next ten years.
The automated cell biology systems market is expected to reach USD 33.5 Billion by end of 2032 at a CAGR of 9.0%.
The growing geriatric population, the rising burden of chronic and infectious diseases, and rising Research and Development on novel biopharmaceuticals are some of the key trends in this market.
By region, North America holds the highest market share of around 37.4% by value, in 2021, in the global automated cell biology systems market.
Europe is projected to grow with a CAGR of 7.5% during the forecast period.
The USA, Germany, India, China, and the United Kingdom are the top five countries, which are expected to drive demand in the automated cell biology systems market.
Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Hitachi. Ltd, Nanoentek, ChemoMetec, Danaher Corporation, Agilent Technologies, Perkin Elmer (Nexcelom Bioscience LLC.), F. Hoffmann-La Roche AG, SHIMADZU CORPORATION, Bio-Rad Laboratories, Miltenyi Biotec, Sinfonia Technology, SHIBUYA CORPORATION, Advanced Instruments, Cell Culture Company, LLC, BD, and Hamilton Company, are some of the key players in the automated cell biology systems industry.
From 2015 to 2021, the market for automated cell biology systems expanded at the rate of 6.6% CAGR.
The automated cell biology systems market in South Asia is expected to grow at 12.3% CAGR during the forecast period.
East Asia is set to present lucrative growth at a CAGR of 13.1% during the forecasted years.
Explore Similar Insights
Automated Cell Biology Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
